No Data
No Data
10-Q: Quarterly report
Express News | Eterna Therapeutics Announces Appointment of Mahendra Rao, Phd, to Its Scientific Advisory Board
Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to Its Scientific Advisory Board
CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) ("Eterna" or the "Company"), a preclinical-stage biopharmaceutical company, committed to realizing the pote
Press Release: Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to Its Scientific Advisory Board
Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) ("Eterna" o
Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) IMSC Line With Enhanced Immunosuppressive Activity and Stealthing Features That May Further Augment the Therapeutic Potential of...
Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) IMSC Line With Enhanced Immunosuppressive Activity and Stealthing Features That
Factor Bioscience Expands Translational Science Team, Appoints Kyle Garland, Ph.D., as Director of Translational Science
CAMBRIDGE, Mass., April 9, 2024 /PRNewswire/ -- Factor Bioscience Inc. ("Factor"), a Cambridge, Massachusetts-based biotechnology company developing advanced mRNA and cell-engineering technologies, t
No Data